Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BYScientific Reports

Modulating SPARC expression in mesenchymal stem cells improves MSCs-mediated skin regeneration and wound repair

  1. 1INEU-CONICET, FLENI
  2. 2Cátedra de Citología, Histología y Embriología, FCM, UNLP

Abstract

Mesenchymal stem cells (MSCs) have garnered significant attention over the past three decades due to their robust regenerative potential, primarily mediated through their paracrine activity, involving the release of soluble bioactive factors and extracellular vesicles (EVs). The MSC secretome plays a pivotal role in wound healing by influencing cellular migration, inflammation, angiogenesis, extracellular matrix (ECM) remodeling, and re-epithelialization. SPARC (Secreted Protein Acidic and Rich in Cysteine), a multifunctional ECM glycoprotein involved in tissue repair and remodeling, regulates key processes such as cell migration, proliferation, angiogenesis, and survival. Despite its known role in ECM dynamics, the impact of SPARC expression on the regenerative properties of MSCs remains underexplored. In this study, we hypothesized that SPARC overexpression in MSCs enhances their regenerative capacity. Using lentiviral systems, we generated SPARC-overexpressing (+ SPARC) and SPARC-knockdown (KD-SPARC) MSCs to investigate SPARC’s role in wound healing. Conditioned media (CM) derived from these MSCs were analyzed in vitro for their effects on human skin keratinocytes and fibroblasts. Our results revealed that SPARC expression significantly influences cell-specific migration and cell cycle progression. Furthermore, in an in vivo wound healing model, CM from +SPARC MSCs accelerated regeneration, whereas the absence of SPARC in MSC-derived CM delayed the healing process. These findings underscore the critical role of SPARC in modulating MSCs functionality and enhancing the regenerative efficacy of their CM. This study highlights SPARC as a promising therapeutic target for the development of advanced regenerative therapies aimed at improving cutaneous wound healing outcomes.

Related

  1. Matrigel scaffold, alone or with human placenta-derived mesenchymal stromal cells, improves histological repair of murine excisional wounds
    Roya Saeedifar, Ramyar Rahimi Darehbagh, Arefeh Jafarian +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  2. Peri-Ovarian Mitochondrial Administration Improves Surrogate Markers of Ovarian Function in Aged Rats: Free Versus Alginate-Encapsulated Mesenchymal Stromal Cell-Derived Mitochondria
    Zehra Seda Halbutoğulları, Zeynep Ece Utkan Korun, Gülşen Çelebi +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Zhuyu pill relieves cholestasis in rats by modulating the expression of lncRNAs and circRNAs
    Fenghua Zhang, Rui Cheng, Zhili Zheng +3
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Isoliquiritigenin inhibits TGF-β1-induced epithelial–mesenchymal transition in pulmonary fibrosis by promoting Nix-mediated mitophagy
    Shaorui Ke, Tiantian Liu, Qin Hu +4
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  5. The long noncoding RNA MAPKAPK5-AS1 promotes the formation of hepatitis B virus cccDNA by modulating the expression of NABP1.
    Xiaolu Zhang, Tingting Liu, Qiuyue Jiang +3
    VirulencePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@article{lombardi2026modulating,
  title = {{Modulating SPARC expression in mesenchymal stem cells improves MSCs-mediated skin regeneration and wound repair}},
  author = {A. Lombardi and J. Smucler and M. B. Palma and A. Iribarne and A. La Greca and M. N. García and A. Waisman and L. N. Moro and G. E. Sevlever and S. G. Miriuka and C. D. Luzzani},
  journal = {Scientific Reports},
  year = {2026},
  month = jul,
  doi = {10.1038/s41598-026-62848-x},
  url = {https://doi.org/10.1038/s41598-026-62848-x},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Modulating SPARC expression in mesenchymal stem cells improves MSCs-mediated skin regeneration and wound repair
AU  - A. Lombardi
AU  - J. Smucler
AU  - M. B. Palma
AU  - A. Iribarne
AU  - A. La Greca
AU  - M. N. García
AU  - A. Waisman
AU  - L. N. Moro
AU  - G. E. Sevlever
AU  - S. G. Miriuka
AU  - C. D. Luzzani
PY  - 2026
DA  - 2026/07/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-62848-x
UR  - https://doi.org/10.1038/s41598-026-62848-x
AB  - Mesenchymal stem cells (MSCs) have garnered significant attention over the past three decades due to their robust regenerative potential, primarily mediated through their paracrine activity, involving the release of soluble bioactive factors and extracellular vesicles (EVs). The MSC secretome plays a pivotal role in wound healing by influencing cellular migration, inflammation, angiogenesis, extracellular matrix (ECM) remodeling, and re-epithelialization. SPARC (Secreted Protein Acidic and Rich in Cysteine), a multifunctional ECM glycoprotein involved in tissue repair and remodeling, regulates key processes such as cell migration, proliferation, angiogenesis, and survival. Despite its known role in ECM dynamics, the impact of SPARC expression on the regenerative properties of MSCs remains underexplored. In this study, we hypothesized that SPARC overexpression in MSCs enhances their regenerative capacity. Using lentiviral systems, we generated SPARC-overexpressing (+ SPARC) and SPARC-knockdown (KD-SPARC) MSCs to investigate SPARC’s role in wound healing. Conditioned media (CM) derived from these MSCs were analyzed in vitro for their effects on human skin keratinocytes and fibroblasts. Our results revealed that SPARC expression significantly influences cell-specific migration and cell cycle progression. Furthermore, in an in vivo wound healing model, CM from +SPARC MSCs accelerated regeneration, whereas the absence of SPARC in MSC-derived CM delayed the healing process. These findings underscore the critical role of SPARC in modulating MSCs functionality and enhancing the regenerative efficacy of their CM. This study highlights SPARC as a promising therapeutic target for the development of advanced regenerative therapies aimed at improving cutaneous wound healing outcomes.
SN  - 2045-2322
ER  -